---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-007658"
form_type: "8-K"
ticker: "SNTI"
cik: "0001854270"
company_name: "Senti Biosciences, Inc."
filed_at: "2025-03-07T23:59:59+00:00"
generated_at: "2026-05-25T04:00:44.852920+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Senti Biosciences stockholders approve share issuance and amended equity plan

## Summary
- Approved issuance of common stock upon conversion of Series A preferred and exercise of warrants (2,442,111 for, 125,063 against).
- Approved Amended and Restated 2022 Equity Incentive Plan (2,196,615 for, 371,748 against).
- Approved adjournment to solicit additional proxies if needed (2,258,129 for).
- Equity plan adds 4,816,434 shares plus annual 5% evergreen increase through 2034.

## SEC filing metadata
- accession: 0001140361-25-007658
- form_type: 8-K
- ticker: SNTI
- cik: 0001854270
- company_name: Senti Biosciences, Inc.
- filed_at: 2025-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854270/000114036125007658/0001140361-25-007658-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854270/000114036125007658/ef20045105_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-007658
- JSON: https://secwatch.observer/filing/0001140361-25-007658.json
- Plain text: https://secwatch.observer/filing/0001140361-25-007658.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.